EndocrinologyEfficacy and Safety of Relacorilant for the Treatment of Patients With Cushing’s Syndrome (GRACE): A Multicentre, Phase 3, Double-Blind, Placebo-Controlled, Randomised-Withdrawal StudyPivonello • 2026 • The Lancet Diabetes & Endocrinology February 20, 2026